distribution happening, page-10

re: distribution happening; ripped Upon completion of these preparatory steps and the receipt of regulatory approvals, Heart Ware plans to initiate a series of human trials in Australia and the EU in late 2005, and then in the US in 2006.

HeartWare intends to use the data from the Australian and EU human trials in order to support applications for an Investigational Device Exemption ("IDE") for US bridge to transplant and destination therapy clinical trials.